The Fund will take exposure of at least two thirds of its total assets to equities of companies all over the world which operate or benefit from developments in technologies, products or services in the areas of healthy nutrition, health treatment, diagnosis and system efficiency, or physical activities, and good hygiene. This includes companies incorporated or having the major part of their business activities in mature economies (developed markets) as well as in developing economies (emerging markets) and which show an elevated degree of sustainability.